Announced Fri, 5 Sept · 17:26 IST

Annual Report of the Company for the FY 2024-25

Revenue DeclineRelated Party TransactionsResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Bandaram Pharma Packtech Limited has submitted its Annual Report for FY 2024-25 along with the AGM notice. The AGM is scheduled for September 29, 2025 via video conferencing. The Board has recommended a final dividend of Rs. 0.10 per equity share (on face value Rs. 10), with record date September 22, 2025. Financial performance shows turnover declining to Rs. 1,222.83 lakhs from Rs. 1,483.91 lakhs in FY 2023-24 (a drop of about 17.6%), while net profit after tax improved marginally to Rs. 14.00 lakhs from Rs. 12.84 lakhs. Items to be approved at the AGM include appointment of M/s. Manoj Parakh & Associates as Secretarial Auditors for 5 years, re-appointment of Mr. Deepak Reddy B as Chairman & MD for 3 years at Rs. 3 lakh per month, and approval of material related party transactions with subsidiary VSR Paper and Packaging Limited up to Rs. 100 crore for sales/purchase.

Likely market impact

Shareholders may note the decline in revenue despite a small uptick in profits, suggesting margin improvement. The Rs. 0.10 per share dividend is modest. The large related party transaction limit (Rs. 100 crore) with the subsidiary is significant and warrants shareholder attention given the size relative to the company's turnover.